NCT04562246View on ClinicalTrials.gov

SARS-CoV-2 IgG and IgM Serologic Assays

CompletedOBSERVATIONAL
Enrollment

214

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

March 22, 2021

Study Completion Date

February 26, 2024

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Serologic assays for antibodies to SARS-CoV-2

Beckman Coulter and Roche automated immunoassays

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT04562246 - SARS-CoV-2 IgG and IgM Serologic Assays | Biotech Hunter | Biotech Hunter